Peptide questions · Petrelintide

How long does petrelintide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Petrelintide’s onset is days–2 weeks, its peak effect comes at 42 weeks (phase 2, still falling), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 (Brændholt Olsen 2026, Diabetes Obes Metab), ZUPREME-1 (Garvey 2026, Lancet Diabetes Endocrinol; NCT06662539), Zealand release Oct-7-2026 (ZUPREME-2), ZUPREME-3/4/5 records on ClinicalTrials.gov. Investigational.

Petrelintide week by week

The library places six of its research notes on petrelintide on the days they cover, from day 1 to day 294: 5 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The petrelintide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Fullness, gentlyRandomized trial
Days 29–294 (weeks 5–42)Low doses already workRandomized trial
Days 57–294 (weeks 9–42)Five milligramsRandomized trial
Days 85–294 (weeks 13–42)The top dose testedRandomized trial
Days 85–294 (weeks 13–42)With type 2 diabetesClinical data
Days 197–294 (weeks 29–42)Weeks 28 to 42: still movingRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track petrelintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The petrelintide timeline’s milestones

The library’s timeline for petrelintide marks 5 points from week 1 to week 42, backed by moderate evidence overall.

  • Week 1: Commonly reported: feeling full sooner at meals
  • Week 4: Its phase 2 trials stepped the dose up every 4 weeks, for up to 16 weeks
  • Week 16: Phase 1: up to about 8.6% loss after 16 weekly doses, without diet advice
  • Week 28: ZUPREME-1 endpoint: about 8% to 10% average loss vs about 2% on placebo
  • Week 42: ZUPREME-1 end: up to about 10.7% average loss, still coming down

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why petrelintide takes that long

Petrelintide’s half-life is about 10 days (240 hours), so one dose is about 96.9% cleared after 50 days.

On its schedule (Weekly) the doses overlap, and the level of petrelintide keeps climbing for about 40–50 days before it levels off, so the first 40–50 days run below the level the later weeks hold.

The notes on petrelintide follow the trials’ dose steps, 2.5mg, 5mg and 9mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Petrelintide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, petrelintide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does petrelintide take to work?

Petrelintide’s onset is days–2 weeks, its peak effect comes at 42 weeks (phase 2, still falling), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does petrelintide reach its peak effect?

By the library’s timeline, petrelintide’s peak effect comes at 42 weeks (phase 2, still falling), backed by moderate evidence.

How long is petrelintide usually run?

The library’s timeline gives petrelintide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 42 weeks in ZUPREME-1 and 28 weeks in ZUPREME-2, with steps every 4 weeks.

What does the library say about the first days on petrelintide?

Its first note on petrelintide, for days 1–28 (weeks 1–4), is “Fullness, gently”, resting on randomized trials.

More on petrelintide

Track it in the app

PepVault for iPhone

Track petrelintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo